Diagnostic procedures using radiolabeled colloidal bismuth subci

Details Diagnostic procedures using radiolabeled colloidal bismuth subci Diagnostic procedures using radiolabeled colloidal bismuth subci

1984-04-27

1987-06-02

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

424 9, A61K 4300, A61K 4902

Patent

active

046702458

ABSTRACT:
An unusual diagnostic procedure for the in vivo clinical evaluation of gastrointestinal ulcer disease and other diseases associated with loss of mucosal integrity in both animals and humans which comprises the oral administration of an effective amount of radiolabeled colloidal bismuth subcitrate or other ulcer avid bismuth compound to an animal or human host, followed by scintigraphic imaging of the gastrointestinal area of interest with scintigraphic imaging equipment. Also disclosed is a novel radiopharmaceutical composition comprising an aqueous solution or suspension containing an amount of a radiolabeled bismuth-protein complex effective for in vivo scintigraphic imaging of the gastrointestinal or other mucosal areas in animals and humans.

REFERENCES:
patent: 3852413 (1974-12-01), Cammarata
patent: 4115540 (1978-09-01), Digenis et al.
patent: 4243652 (1981-01-01), Francis

Affiliated with

Also associated with

Rating

Diagnostic procedures using radiolabeled colloidal bismuth subci does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostic procedures using radiolabeled colloidal bismuth subci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic procedures using radiolabeled colloidal bismuth subci will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-612483